Similar results were also observed in other human malignancies, such as esophageal, gastric, colon, and breast cancers [12,16], in which the overexpression of the ATAD2 gene was often observed in more aggressive tumor subgroups and provided diagnostic value. This evidence concerns the gene ATAD2 and neoplasm.